Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Ordinary Shares, par value CHF 0.05 per share
-
Shares outstanding
-
66.4M
-
Number of holders
-
33
-
Total 13F shares, excl. options
-
17.9M
-
Shares change
-
-400K
-
Total reported value, excl. options
-
$80.2M
-
Value change
-
-$1.83M
-
Number of buys
-
9
-
Number of sells
-
-14
-
Price
-
$4.48
Significant Holders of SOPHiA GENETICS SA - Ordinary Shares, par value CHF 0.05 per share (SOPH) as of Q2 2023
37 filings reported holding SOPH - SOPHiA GENETICS SA - Ordinary Shares, par value CHF 0.05 per share as of Q2 2023.
SOPHiA GENETICS SA - Ordinary Shares, par value CHF 0.05 per share (SOPH) has 33 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17.9M shares
of 66.4M outstanding shares and own 26.95% of the company stock.
Largest 10 shareholders include GENERATION INVESTMENT MANAGEMENT LLP (6.79M shares), BANQUE PICTET & CIE SA (2.19M shares), CREDIT SUISSE AG/ (1.93M shares), MILLENNIUM MANAGEMENT LLC (1.62M shares), Alta Wealth Advisors LLC (1.41M shares), PRINCIPAL FINANCIAL GROUP INC (987K shares), PRICE T ROWE ASSOCIATES INC /MD/ (959K shares), PURA VIDA INVESTMENTS, LLC (610K shares), BlackRock Inc. (299K shares), and Bank Pictet & Cie (Europe) AG (228K shares).
This table shows the top 33 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.